BRAVELLE

This brand name is authorized in Ecuador, Estonia, Lithuania, Poland, Singapore, South Africa

Active ingredients

The drug BRAVELLE contains one active pharmaceutical ingredient (API):

1 Urofollitropin
UNII W9BB98U6HP - UROFOLLITROPIN

Urofollitropin contains a highly purified preparation of urinary FSH extracted from the urine of postmenopausal women. FSH stimulates ovarian follicular growth and development as well as gonadal steroid production in women who do not have primary ovarian failure.

Read about Urofollitropin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
BRAVELLE Powder and solvent for solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
G03GA04 Urofollitropin G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03G Gonadotropins and other ovulation stimulants → G03GA Gonadotropins
Discover more medicines within G03GA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 29113-12-09
Country: EE Ravimiamet Identifier(s): 1307001, 1307012, 1402782
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1026274, 1026596
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100193237
Country: SG Health Sciences Authority Identifier(s): 14420P
Country: ZA Health Products Regulatory Authority Identifier(s): 44/21.10/0763

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.